Titre : Érythrokératodermie variabilis

Érythrokératodermie variabilis : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Fields
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Érythrokératodermie variabilis : Questions médicales les plus fréquentes", "headline": "Érythrokératodermie variabilis : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Érythrokératodermie variabilis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-24", "dateModified": "2025-03-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Érythrokératodermie variabilis" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies génétiques de la peau", "url": "https://questionsmedicales.fr/mesh/D012873", "about": { "@type": "MedicalCondition", "name": "Maladies génétiques de la peau", "code": { "@type": "MedicalCode", "code": "D012873", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.827" } } }, "about": { "@type": "MedicalCondition", "name": "Érythrokératodermie variabilis", "alternateName": "Erythrokeratodermia Variabilis", "code": { "@type": "MedicalCode", "code": "D056266", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yuuki Kodama", "url": "https://questionsmedicales.fr/author/Yuuki%20Kodama", "affiliation": { "@type": "Organization", "name": "Institute of Agricultural and Life Sciences, Academic Assembly, Shimane University, Matsue-shi, Japan. kodama@life.shimane-u.ac.jp." } }, { "@type": "Person", "name": "Matthew E M Yunik", "url": "https://questionsmedicales.fr/author/Matthew%20E%20M%20Yunik", "affiliation": { "@type": "Organization", "name": "Department of Biology, University of Saskatchewan, Saskatoon, SK, Canada." } }, { "@type": "Person", "name": "Neil B Chilton", "url": "https://questionsmedicales.fr/author/Neil%20B%20Chilton", "affiliation": { "@type": "Organization", "name": "Department of Biology, University of Saskatchewan, Saskatoon, SK, Canada." } }, { "@type": "Person", "name": "Chulantha P Diyes", "url": "https://questionsmedicales.fr/author/Chulantha%20P%20Diyes", "affiliation": { "@type": "Organization", "name": "Department of Biology, University of Saskatchewan, Saskatoon, SK, Canada." } }, { "@type": "Person", "name": "Mirye Park", "url": "https://questionsmedicales.fr/author/Mirye%20Park", "affiliation": { "@type": "Organization", "name": "Protist Research Team, Microbial Research Department, Nakdonggang National Institute of Biological Resources, Sangju, 37242, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prediction of visual field progression in glaucoma: existing methods and artificial intelligence.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37540325", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10384-023-01009-3" } }, { "@type": "ScholarlyArticle", "name": "A Novel Visual Field Screening Program for Glaucoma With a Head-Mounted Perimeter.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36847662", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002199" } }, { "@type": "ScholarlyArticle", "name": "Teleglaucoma Using a New Smartphone-Based Tool for Visual Field Assessment.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36730078", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002153" } }, { "@type": "ScholarlyArticle", "name": "Differences in eccentricity for sound-induced flash illusion in four visual fields.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36397675", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03010066221136670" } }, { "@type": "ScholarlyArticle", "name": "Iridotomy to slow progression of visual field loss in angle-closure glaucoma.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36621864", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD012270.pub3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la peau", "item": "https://questionsmedicales.fr/mesh/D012871" }, { "@type": "ListItem", "position": 4, "name": "Maladies génétiques de la peau", "item": "https://questionsmedicales.fr/mesh/D012873" }, { "@type": "ListItem", "position": 5, "name": "Érythrokératodermie variabilis", "item": "https://questionsmedicales.fr/mesh/D056266" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Érythrokératodermie variabilis - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Érythrokératodermie variabilis", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Érythrokératodermie variabilis", "description": "Comment diagnostiquer l'érythrokératodermie variabilis ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent cette maladie ?\nL'érythrokératodermie variabilis est-elle héréditaire ?\nPeut-on confondre cette maladie avec d'autres ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Érythrokératodermie variabilis", "description": "Quels sont les principaux symptômes ?\nLes symptômes varient d'une personne à l'autre ?\nY a-t-il des symptômes associés ?\nLes symptômes s'aggravent-ils avec le temps ?\nLes symptômes peuvent-ils être déclenchés par des facteurs externes ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Érythrokératodermie variabilis", "description": "Peut-on prévenir l'érythrokératodermie variabilis ?\nComment gérer les symptômes au quotidien ?\nY a-t-il des conseils pour la peau ?\nLes soins de la peau sont-ils importants ?\nLes patients doivent-ils éviter certains aliments ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Érythrokératodermie variabilis", "description": "Quels traitements sont disponibles ?\nLes traitements sont-ils efficaces ?\nDes traitements alternatifs existent-ils ?\nLes traitements nécessitent-ils un suivi médical ?\nY a-t-il des effets secondaires aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Érythrokératodermie variabilis", "description": "Quelles complications peuvent survenir ?\nL'érythrokératodermie variabilis augmente-t-elle le risque de cancer ?\nLes complications affectent-elles la qualité de vie ?\nDes complications psychologiques peuvent-elles survenir ?\nLes complications nécessitent-elles une intervention médicale ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Érythrokératodermie variabilis", "description": "Quels sont les facteurs de risque connus ?\nL'environnement joue-t-il un rôle ?\nLes infections peuvent-elles déclencher des symptômes ?\nLe stress influence-t-il la maladie ?\nY a-t-il des groupes à risque spécifique ?", "url": "https://questionsmedicales.fr/mesh/D056266?mesh_terms=Visual+Fields&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'érythrokératodermie variabilis ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique familial, parfois confirmé par une biopsie cutanée." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être effectués pour identifier des mutations spécifiques associées à la maladie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent cette maladie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des plaques rouges et squameuses sur la peau, souvent avec des zones de kératose, sont typiques." } }, { "@type": "Question", "name": "L'érythrokératodermie variabilis est-elle héréditaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est généralement transmise de manière autosomique dominante dans les familles." } }, { "@type": "Question", "name": "Peut-on confondre cette maladie avec d'autres ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres dermatoses comme le psoriasis ou l'ichtyose." } }, { "@type": "Question", "name": "Quels sont les principaux symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des plaques rouges, des démangeaisons et une peau squameuse." } }, { "@type": "Question", "name": "Les symptômes varient d'une personne à l'autre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et l'étendue des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies des ongles et des cheveux peuvent également être observées chez certains patients." } }, { "@type": "Question", "name": "Les symptômes s'aggravent-ils avec le temps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent fluctuer, mais ils ont tendance à persister tout au long de la vie." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être déclenchés par des facteurs externes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress, les infections ou les irritants cutanés peuvent aggraver les symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir l'érythrokératodermie variabilis ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Étant une maladie génétique, il n'existe pas de méthode de prévention connue." } }, { "@type": "Question", "name": "Comment gérer les symptômes au quotidien ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation régulière d'émollients et l'évitement des irritants cutanés peuvent aider." } }, { "@type": "Question", "name": "Y a-t-il des conseils pour la peau ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de garder la peau hydratée et de protéger les zones affectées du soleil." } }, { "@type": "Question", "name": "Les soins de la peau sont-ils importants ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés peuvent réduire l'inconfort et améliorer l'apparence de la peau." } }, { "@type": "Question", "name": "Les patients doivent-ils éviter certains aliments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de régime spécifique, mais une alimentation équilibrée peut soutenir la santé globale." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des émollients, des corticostéroïdes topiques et des thérapies systémiques." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent aider à soulager les symptômes, mais il n'existe pas de cure définitive." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies comme la photothérapie peuvent être envisagées pour certains patients." } }, { "@type": "Question", "name": "Les traitements nécessitent-ils un suivi médical ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour ajuster les traitements et surveiller les effets secondaires." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements peuvent entraîner des effets secondaires comme l'amincissement de la peau." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections cutanées peuvent survenir en raison de la peau endommagée et des lésions." } }, { "@type": "Question", "name": "L'érythrokératodermie variabilis augmente-t-elle le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de preuve claire que cette maladie augmente le risque de cancer de la peau." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes et les complications peuvent avoir un impact significatif sur la qualité de vie." } }, { "@type": "Question", "name": "Des complications psychologiques peuvent-elles survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'impact esthétique et les démangeaisons peuvent entraîner des problèmes psychologiques." } }, { "@type": "Question", "name": "Les complications nécessitent-elles une intervention médicale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent nécessiter des soins médicaux supplémentaires pour être gérées." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de la maladie sont le principal facteur de risque identifié." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Bien que l'environnement ne soit pas un facteur direct, des irritants peuvent aggraver les symptômes." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher des symptômes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections cutanées peuvent exacerber les symptômes de la maladie." } }, { "@type": "Question", "name": "Le stress influence-t-il la maladie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes et provoquer des poussées cutanées." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque spécifique ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents familiaux sont plus susceptibles de développer la maladie." } } ] } ] }

Sources (10000 au total)

A Novel Visual Field Screening Program for Glaucoma With a Head-Mounted Perimeter.

A novel visual field screening program with a head-mounted perimeter 'imo' could detect glaucoma at all stages in a short time with high accuracy.... The present study aimed to examine the accuracy and availability of a novel glaucoma visual field screening program using a head-mounted visual perimeter 'imo.'... Eyes of 76 non-glaucoma participants and 92 glaucoma patients were examined. All patients underwent visual field tests using the Humphrey Visual Field Analyzer (30-2 or 24-2 Swedish Interactive Thresh... The sensitivity, specificity, positive predictive value, and negative predictive value of the visual field screening program were 76%-100%, 91%-100%, 86%-89%, and 79%-100%, respectively. The visual fi... Visual field screening using a head-mounted perimeter 'imo' detected glaucoma at all stages in a short time with high accuracy....

Teleglaucoma Using a New Smartphone-Based Tool for Visual Field Assessment.

COVID-19 underlines the importance of telemedical diagnostics. The smartphone-based campimetry (Sb-C) is a newly developed digital application allowing visual field testing using a head-mounted device... Sb-C is a newly developed tool for functional ophthalmic diagnosis. This study aimed to examine the comparability of the Sb-C and Octopus 900 to ensure ophthalmological care in times of social distanc... Total 93 eyes were included in the study. After an ophthalmological examination, the visual field was tested by the Octopus program G1 and by the smartphone-based campimeter. The Sb-C was performed us... The group comprised 48 women and 45 men (mean age: 62.52±12.2 y) including 19 controls, 17 patients with ocular hypertension, 11 preperimetric glaucomas, and 46 perimetric glaucomas. The mean sensitiv... With some technical adjustments, the Sb-C shows promise for screening glaucoma and monitoring disease progression remotely from an ophthalmologic clinic....

Iridotomy to slow progression of visual field loss in angle-closure glaucoma.

Primary angle-closure glaucoma is a type of glaucoma associated with a physically obstructed anterior chamber angle. For example, contact between the iris and lens at the pupillary margin creates a pu... To assess the effects of iridotomy compared with no iridotomy for primary angle-closure glaucoma, primary angle-closure, and primary angle-closure suspect.... We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2021, Issue 10), which contains the Cochrane Eyes and Vision Trials Register; MEDLINE Ovid; Embase Ovid; PubMed; LILACS; Clinic... Randomized or quasi-randomized controlled trials that compared iridotomy with no iridotomy in primary angle-closure suspects, people with primary angle-closure, or people with primary angle-closure gl... We used standard Cochrane methodology and assessed the certainty of the body of evidence for prespecified outcomes using the GRADE approach.... We identified four studies (3086 eyes of 1543 participants) that compared iridotomy with no iridotomy in participants (range of mean age 59.6 to 62.9 years) who were primary angle-closure suspects fro...

The Effects of Visual Field Loss from Stroke on Performance in a Driving Simulator.

Visual field loss is a common consequence of stroke and often precludes driving. However, legal visual requirements for drivers' licenses are largely without scientific basis.... This study aimed to examine the effects of different types of homonymous visual field loss after stroke on simulated driving.... Data on performance and safety from a traffic simulator test for 153 participants with withdrawn drivers' licenses due to visual field loss from stroke were retrospectively compared with data from 83 ... Sixty-five percent of the stroke participants passed the simulator test (95% confidence interval, 57 to 72%). Younger patients were more successful than older. However, classification by neither type ... In this large cohort, driver safety could not be predicted from the type of homonymous visual field loss. Even individuals with severe visual field loss might be safe drivers. Therefore, it seems reas...

Comparing a head-mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients.

To compare clinical visual field outputs in glaucoma and healthy patients returned by the Humphrey Field Analyzer (HFA) and virtual reality (Virtual Field, VF) perimetry.... One eye of 54 glaucoma patients and 41 healthy subjects was prospectively tested (three times each in random order) using the HFA and VF perimeters (24-2 test grids). We extracted and compared global ... The VF test was shorter (by 76 s) and had lower fixation losses (by 0.08) and false-positive rate (by 0.01) compared to the HFA (all p < 0.0001). Intraclass correlations were 0.86, 0.82 and 0.47 for M... Virtual Field returns global results that are correlated with the HFA, but pointwise sensitivities were more variable. Differences in test-retest variability and defect detection by its current normat...